PriceSensitive

Pure Extracts (CSE:PULL) receives re-order from Abba Medix

Cannabis
CSE:PULL
05 November 2021 10:15 (EDT)

Pure Extracts Technology Corp’s (PULL) subsidiary has received a re-order from Abba Medix Corp. for sale to their established medical patient base.

Included in the re-order are several SKUs of the subsidiary, Pure Extracts Manufacturing Corp., “Pure Pulls” branded line of full-spectrum oil THC vape products.

Also included are blister-packaged gummy products, such as its high potency 50 milligram CBD Pure Chews.

The branded products also feature 75 milligram and 100 milligram CBD potencies.

Demand for these types of products is strong in the adult recreational and medical segments that the company has launched its cannabis products in.

Ben Nikolaevsky, Pure Extracts’ CEO, commented, “We are pleased to be getting good sell-through in the medical cannabis space which will make a significant revenue contribution starting in Q4 and ramping up in 2022.”

Pure Extracts Technology Corp. features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia.

The facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available.

“Abba’s extensive military and medical customer base along with their popular online portal allows us to quickly and efficiently get our outstanding line of full spectrum oil CBD and THC vape products and high potency CBD chews, to their patients across Canada,” said Nikolaevsky.

Pure Extracts Technologies Corp (PULL) is up 2.78 per cent and is trading at $0.185 per share at 1.18 p.m. ET.

Related News